---
category: news
title: "Castle Biosciences Publishes DecisionDx®-Melanoma Study on the Validation of the i31-GEP SLNB Artificial Intelligence Algorithm"
excerpt: "Castle Biosciences, Inc. (Nasdaq: CSTL), a company applying innovative diagnostics to inform disease management and improve patient outcomes, today announced the publication of a study validating performance of a novel algorithm designed to integrate the DecisionDx ® -Melanoma gene expression profile (GEP) test with clinicopathologic features (i31-GEP SLNB) to determine sentinel lymph node biopsy (SLNB) positivity risk in patients with cutaneous melanoma."
publishedDateTime: 2021-11-05T21:01:00Z
originalUrl: "https://apnews.com/press-release/BusinessWire/coronavirus-pandemic-science-technology-business-melanoma-b54532c71d214233b100c84c9001449d"
webUrl: "https://apnews.com/press-release/BusinessWire/coronavirus-pandemic-science-technology-business-melanoma-b54532c71d214233b100c84c9001449d"
type: article
quality: 11
heat: 11
published: false

provider:
  name: Associated Press
  domain: apnews.com

topics:
  - AI
  - AI in Healthcare

images:
  - url: "https://apnews.com/images/PaidContent3.png"
    width: 700
    height: 450
    isCached: true

secured: "RZtokZUMk+uq3f9C/3WyQzs0/u9NOKbwskwSoVSfW5/uV3i9K8AsEZtQj8FYXNFMI1ASrWNml/tZc6HH6na2ISOLaXoUD3BUZ9VF10DdvPJJJMkYjZ1JkHwfCn05mK7/7Z20LK/YXDo6XFIcxPcHBGOAYELU1eHN/6YNFfoVh4OVIDnfXvY3RCwTjXtrfmCVzTo6FLGpjJzqTDnVvENspF3+4l7WmGRDYk6qsNRsRMURTpJJwLiq+iqnrVFSechdGX6lAvpiebGd2Gj5GR+aM7819Wd1acZo+8OynHGLF+wtTFUfdrBt8Pw0z4ZtqBJHEYPiQEQK0myUPz7KEGq9WT5aEX/yN/uGpXQEDxfqLGA=;4Po03QHtVS0KiEQUF0yaFg=="
---

